Alemtuzumab as graft-versus-host disease (GVHD) prophylaxis strategy in a developing country: lower rate of acute GVHD, increased risk of cytomegalovirus reactivation

por Resende, C.B., Rezende, B.M., Bernardes, P.T.T., Teixeira, G.M., Teixeira, M.M., Pinho, V., Bittencourt, H.
Publicado 2017

Neutrophil activity in sepsis: a systematic review

por Resende, C.B., Borges, I., Gonçalves, W.A., Carneiro, R., Rezende, B.M., Pinho, V., Nobre, V., Teixeira, M.M.
Publicado 2020